A practitioner for over 25 years, Koff is leading a transformative movement in personalized nutrition, turning better, not perfect choices into practical, sustainable strategies that deliver real health outcomes
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronies disease and erectile dysfunction: results from a prospective randomized trial
In sintesi: semaglutide 7,2 mg produce una perdita di peso significativamente maggiore rispetto a 2,4 mg con quasi il 50% dei pazienti oltre il 20% e quasi il 31% oltre il 25%, soglie praticamente sovrapponibili a quelle del tirzepatide nel confronto indiretto con un profilo di tollerabilit complessivamente favorevole
But it's not magic
Tirzepatide was initially approved by the FDA under the brand name Mounjaro for adults, helping to improve blood sugar
Wegovy is explicitly approved for weight loss in adults and adolescents age 12 and older